News

As interest in medical uses of cannabis constituents grows, researchers are closely examining how cannabidiol (CBD), a naturally occurring compound in plants, impacts health, especially regarding cancer and inflammatory diseases. CBD is recognized for its antidepressant, anxiolytic, and antiepileptic properties, and now, scientists are exploring its ability to regulate essential cellular functions like autophagy and … Read more

In a promising development for lung cancer treatment, a recent study has unveiled that combining low doses of the chemotherapy drug dasatinib with cannabidiol (CBD), a compound derived from cannabis, significantly enhances the efficacy of cancer therapy while reducing its side effects. This groundbreaking research could pave the way for new treatment protocols that are … Read more

In a pivotal study, researchers have identified a promising new treatment approach for glioblastoma (GBM), an aggressive brain cancer with limited effective treatments and a typically poor prognosis. The research focuses on the potential therapeutic effects of inhalant cannabidiol (CBD), a non-psychoactive compound derived from cannabis. Glioblastoma is notoriously challenging due to its fast growth … Read more

In recent research that could redefine treatment approaches for schizophrenia, cannabidiol (CBD), a non-psychoactive component of cannabis, is being highlighted for its potential to manage symptoms associated with the mental health disorder. Schizophrenia, which affects 1% of adults globally, has one of the highest mortality rates among psychiatric conditions, underscoring the urgency for more effective … Read more

In a groundbreaking study, researchers have revealed that CBD may offer new hope in the fight against liver fibrosis. This condition, which can progress to severe liver diseases such as cirrhosis and hepatocellular carcinoma, poses a significant public health challenge. The study utilized a mouse model with liver fibrosis induced by carbon tetrachloride (CCl4), a … Read more